PAS
RXII

Partnervest Advisory Services’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Partnervest Advisory Services’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,000
Closed -$2K – 1164
2013
Q3 		$2K Buy
1,000
+500
+100% +$1K ﹤0.01% 963
2013
Q2 		$1K Buy
+500
New +$1K ﹤0.01% 943

Other funds holding RXII

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Partnervest Advisory Services's RXII Position: Q4 2013 in Review

Partnervest Advisory Services sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2013, closing a stake of 1,000 shares — an estimated $2K sold.

Partnervest Advisory Services first reported a position in RXII in Q2 2013 and held it in 2 quarters. The position peaked at $2K in Q3 2013. 76 funds tracked by Wall St. Rank hold RXII as of Q4 2013.

  • Partnervest Advisory Services reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2013 after selling out during the quarter.
  • Partnervest Advisory Services sold 1,000 GALENA BIOPHARMA INC COM shares in Q4 2013, an estimated $2K.
  • Partnervest Advisory Services first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 2 quarters.
  • Partnervest Advisory Services's GALENA BIOPHARMA INC COM position peaked at $2K in Q3 2013.
  • 76 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2013.

Based on Partnervest Advisory Services's 13F filing for Q4 2013, filed 11 Feb 2014.